Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 56 of the 57 references it cites were found in a registry or an index.

Novel Derivative of Bardoxolone Methyl Improves Safety for the Treatment of Diabetic Nephropathy

Huang, Zhangjian, Mou, Yi, Xu, Xiaojun, Zhao, Di, Lai, Yisheng, Xu, Yuwen, Chen, Cen, Li, Ping, Peng, Sixun, Tian, Jide, Zhang, Yihua · 2017 · Journal of Medicinal Chemistry

Abstract

Currently, no effective and safe medicines are available to treat diabetic nephropathy (DN). Bardoxolone methyl (CDDO-Me) has displayed promising anti-DN activity as well as serious side effects in clinical trials, probably because the highly reactive α-cyano-α,β-unsaturated ketone (CUK) in ring A of CDDO-Me can covalently bind to thiol functionalities in many biomacromolecules. In this study, we designed and synthesized a γ-glutamyl transpeptidase (GGT)-based and CUK-modified derivative of CDDO-Me (2) to address this issue. 2 can be specifically cleaved by GGT, which is highly expressed in the kidney, to liberate CDDO-Me in situ. It should be noted that 2 exhibited anti-DN efficacy comparable to that of CDDO-Me with much less toxicity in cells and db/db mice, suggesting that its safety is better than CDDO-Me. Our findings not only reveal the therapeutic potential of 2 but also provide a strategy to optimize other synthetic molecules or natural products bearing a pharmacophore like CUK to achieve safer pharmaceutical drugs.

Overview

Integrity signals

Registry

Crossref · 10.1021/acs.jmedchem.7b00971

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 57 references

Cited by

See all 41

Metadata

Authors
Huang, Z., Mou, Y., Xu, X., Zhao, D., Lai, Y., Xu, Y., Chen, C., Li, P., Peng, S., Tian, J., & Zhang, Y.
Affiliations
  • University of California, Los Angeles (US)
  • Crystal Pharmatech Co., Ltd., Suzhou 215123, P.R. China
Corresponding author
  • Huang, Zhangjian
  • Xu, Xiaojun
  • Zhang, Yihua
Venue
Journal of Medicinal Chemistry
Published
2017-10-19
Volume
60
Issue
21
Pages
8847-8857
ISSN
  • 0022-2623 (ISSN-L)
  • 1520-4804
OpenAlex
W2763829705
Cited by
40
References
57
Citations by year
2026: 2 · 2025: 4 · 2024: 2 · 2023: 2 · 2022: 5 · 2021: 9 · 2020: 8 · 2019: 5 · 2018: 3
FWCI
3.92
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Medicinal Chemistry (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Program for New Century Excellent Talents in University (NCET-13-1033)
  • National Natural Science Foundation of China (21372261, 21472244, 81673305)
  • Jiangsu Province (BK20160033)
  • Priority Academic Program Development of Jiangsu Higher Education Institutions
Topics
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
  • Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
Keywords
bardoxolone methyl, diabetic nephropathy, gamma-glutamyl transferase, prodrugs, drug safety, thiol reactivity, db/db mice, drug design
MeSH terms
Animals, Diabetic Nephropathies, Drug Therapy, gamma-Glutamyltransferase, Humans, Kidney, Oleanolic Acid, Mice, Rats, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Novel Derivative of Bardoxolone Methyl Improves Safety for the Treatment of Diabetic Nephropathy. https://app.cochat.ai/papers/10.1021/acs.jmedchem.7b00971
The paper
Huang, Z., Mou, Y., Xu, X., Zhao, D., Lai, Y., Xu, Y., Chen, C., Li, P., Peng, S., Tian, J., & Zhang, Y. (2017). Novel Derivative of Bardoxolone Methyl Improves Safety for the Treatment of Diabetic Nephropathy. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.7b00971

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.